Turning biodefense dollars into products-Reference-Cited by-同舟云学术

Turning biodefense dollars into products

Published:2007-02 Issue:2 Volume:25 Page:179-184
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Trull Melanie C,du Laney Tracey V,Dibner Mark D

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt0207-179.pdf

Reference10 articles.

1. Trull, M.C., du Laney, T.V. & Dibner, M.D. Biodefense market report: vaccines, therapeutics, and diagnostics for bioterror agents 2006. BioAbility/BioWorld Atlanta, GA (June 2006).

2. HHS cancels VaxGen's anthrax vaccine contract. (VaxGen, Brisbane, CA, December 19, 2006). http://biz.yahoo.com/prnews/061219/sftu092.html?.v=78

3. Warrick, J. The secretive fight against bioterror. The Washington Post (July 30, 2006) pA01.

4. http://www.cdc.gov/ncidod/diseases/hepatitis/a/fact.htm

5. Trull, M.C., du Laney, T.V. & Dibner, M.D. Biodefense market report: drugs and vaccines for bioterror agents. BioAbility/BioWorld Atlanta, GA (May 2005).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multipathogen DNA vaccine elicits protective immune responses against two class A bioterrorism agents, anthrax and botulism;Applied Microbiology and Biotechnology;2022-02

2. Biodefence research two decades on: worth the investment?;The Lancet Infectious Diseases;2021-08

3. Preparing for the Apocalypse: a Multi-Prong Proposal to Develop Countermeasures for Biological, Chemical, Radiological, and Nuclear Threats;SSRN Electronic Journal;2018

4. Biological Warfare: Infectious Disease and Bioterrorism;Biotechnology;2016

5. Don't be scared, be angry: the politics and ethics of Ebola;Medical Journal of Australia;2014-09